CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026

$300.02−0.13 (-0.04%)

Close on Oct 19, 2026

Community

Notes and questions about Charles River Laboratories International from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Charles River Laboratories International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CRL.

Revenue growth-0.7% · median 8.2%

Operating margin2.3% · median 17.9%

Net margin-6.0% · median 16.1%

Advertisement
300 × 250